Precision Medicine 2030-Reference-Cited by-同舟云学术

Precision Medicine 2030

Published:2019-11-28 Issue:1 Volume:107 Page:62-64
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Pacanowski Michael¹,Liu Qi¹

Affiliation:

1. Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1675

Reference10 articles.

1. Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both

2. 114th Congress.21st Century Cures Act. Accessed July 3 2019.

3. US Food and Drug Administration.PDUFA reauthorization performance goals and procedures fiscal years 2018 through 2022. Accessed July 3 2019.

4. US Food and Drug Administration Center for Drug Evaluation and Research Center for Biologics Evaluation and Research.Guidance for industry: developing targeted therapies in low‐frequency molecular subsets of a disease. Accessed July 7 2019.

5. Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Randomised Controlled Trial at the Intersection of Research Ethics and Innovation;Pharmaceutical Medicine;2022-07-25

2. Quantitative clinical pharmacology and patient-centered healthcare technologies: perspectives 2030;The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation;2022-05-17

3. Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor;Frontiers in Pharmacology;2021-12-09

4. Genetic variability of CYP2D6, CYP3A4 and CYP3A5 among the Egyptian population;Pharmacogenomics;2021-04

5. Clinical Pharmacology & Therapeutics 2030;Clinical Pharmacology & Therapeutics;2019-12-21